Here's Why Iovance Biotherapeutics Jumped 21.2% in December

Shares of Iovance Biotherapeutics (NASDAQ: IOVA) gained over 21% last month, according to data from S&P Global Market Intelligence. There wasn't any company-specific news to send the pharma stock higher. Well, not any new news, anyway. 

Investors continue to rally around shares of Iovance Biotherapeutics after the company reported impressive results for a top drug candidate in late November. The end-of-year rally helped the stock notch a 212% gain in 2019, but shares have given up nearly 8% in the new year. Does that suggest investors are getting a little ahead of themselves?

Image source: Getty Images.

Continue reading

Source Fool.com